The Glycemic Indices of Five Common Varieties of Dates in the Tested Among Healthy and Diabetic Subjects
Launched by UNITED ARAB EMIRATES UNIVERSITY · Mar 2, 2011
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The United Arab Emirates (UAE) has transitioned rapidly over the last 40 years. This has lead to a dramatic increase in the prevalence of obesity, metabolic syndrome, dyslipidaemia, hypertension, prediabetes and diabetes. Daily consumption of dates is the norm.The main objectives of this study is to measure the composition of five common types of dates (Fara'd, Lulu, Abu ouma'n, Dabbas and Khalas) and to calculate their Glycemic Indices (GI) of these dates tested equally in healthy and diabetic subjects. Thirteen healthy volunteers and ten subjects with type 2 diabetes mellitus were enrolle...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult
- • Healthy or having controlled type 2 diabetes mellitus
- Exclusion Criteria:
- • Morbid obesity (BMI \> 40)
- • Presence of gastroenterological disorders
- • Alimentary tract surgery
- • A history of gastroenteritis in the prior six months
- • Any disease that may affect glucose metabolism
- • Alcohol intake
- • Smoking
- • Taking any medications (except metformin)
- • Poorly uncontrolled diabetes (HbA1c \> 8%)
- • The presence of chronic diseases or the presence of acute illness
About United Arab Emirates University
United Arab Emirates University (UAEU) is a leading academic institution dedicated to advancing research and innovation in the region. As a prominent clinical trial sponsor, UAEU leverages its robust academic and scientific resources to conduct rigorous clinical research aimed at improving healthcare outcomes. The university fosters collaboration between multidisciplinary teams, encompassing researchers, healthcare professionals, and industry partners, to address pressing health challenges. Committed to ethical standards and regulatory compliance, UAEU aims to contribute to the global body of medical knowledge while enhancing the quality of care within the UAE and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Al Ain, Abu Dhabi, United Arab Emirates
Patients applied
Trial Officials
Juma M Alkaabi, MD
Principal Investigator
Faculty of Medicine and Health Sciences, UAE University
Bayan Al-Dabbagh, PhD
Study Director
Faculty of Medicine and Health Sciences, UAE University
Professor Hussein saadi, MD
Study Director
Faculty of Medicine and Health Sciences, UAE University
Professor Salah Gariballa, FRCP
Study Director
Faculty of Medicine and Health Sciences, UAE University
Ahmed Shakeel, PhD
Study Director
Abu Dhabi Food Control Authority
Mustafa Al Gazali, PhD
Study Director
Abu Dhabi Food Control Authority
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials